{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:40:36Z","timestamp":1790944836756,"version":"4.1.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T00:00:00Z","timestamp":1294617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0015624","type":"journal-article","created":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T16:54:27Z","timestamp":1294678467000},"page":"e15624","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":183,"title":["HER2-Positive Circulating Tumor Cells in Breast Cancer"],"prefix":"10.1371","volume":"6","author":[{"given":"Michail","family":"Ignatiadis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Roth\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Chaboteaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Durbecq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghizlane","family":"Rouas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Criscitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Metallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naima","family":"Kheddoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep K.","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Michiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Veys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Rossari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Larsimont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Carly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pestrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Buxant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Liebens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Piccart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Sotiriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,1,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrc2375","article-title":"Detection, clinical relevance and specific biological properties of disseminating tumour cells.","volume":"8","author":"K Pantel","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/CCO.0b013e32833de186","article-title":"Circulating tumor cells and emerging blood biomarkers in Breast Cancer.","volume":"22","author":"C Criscitiello","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer.","volume":"351","author":"M Cristofanilli","year":"2004","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1158\/1078-0432.CCR-08-0030","article-title":"Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.","volume":"14","author":"JY Pierga","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1158\/1078-0432.CCR-09-2042","article-title":"Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.","volume":"16","author":"S Riethdorf","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10549-008-9951-2","article-title":"HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer.","volume":"113","author":"JE Lang","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1245\/s10434-010-0918-2","article-title":"Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery.","volume":"17","author":"MT Sandri","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/annonc\/mdp391","article-title":"Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer.","volume":"21","author":"FC Bidard","year":"2010","journal-title":"Ann Oncol"},{"key":"ref9","first-page":"1890","article-title":"ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.","volume":"61","author":"S Braun","year":"2001","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10549-005-9147-y","article-title":"Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients.","volume":"98","author":"EF Solomayer","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1158\/1078-0432.CCR-05-2087","article-title":"HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.","volume":"12","author":"P Wulfing","year":"2006","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/bcr1783","article-title":"Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status.","volume":"9","author":"T Fehm","year":"2007","journal-title":"Breast Cancer Res"},{"key":"ref13","first-page":"1111","article-title":"Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer.","volume":"21","author":"DF Hayes","year":"2002","journal-title":"Int J Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.1073\/pnas.0402993101","article-title":"HER-2 gene amplification can be acquired as breast cancer progresses.","volume":"101","author":"S Meng","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10549-009-0461-7","article-title":"Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.","volume":"118","author":"M Pestrin","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","article-title":"Systemic spread is an early step in breast cancer.","volume":"13","author":"Y Husemann","year":"2008","journal-title":"Cancer Cell"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1097-0320(20010101)43:1<31::AID-CYTO1016>3.0.CO;2-F","article-title":"Cell analysis system based on immunomagnetic cell selection and alignment followed by immunofluorescent analysis using compact disk technologies.","volume":"43","author":"AG Tibbe","year":"2001","journal-title":"Cytometry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","article-title":"Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.","volume":"10","author":"WJ Allard","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cyto.a.20369","article-title":"Statistical considerations for enumeration of circulating tumor cells.","volume":"71","author":"AG Tibbe","year":"2007","journal-title":"Cytometry A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.","volume":"19","author":"CW Elston","year":"1991","journal-title":"Histopathology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.","volume":"17","author":"JM Harvey","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/jcp.53.8.634","article-title":"Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC.","volume":"53","author":"R Leake","year":"2000","journal-title":"J Clin Pathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.","volume":"25","author":"AC Wolff","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","article-title":"Reporting recommendations for tumor marker prognostic studies.","volume":"23","author":"LM McShane","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1515\/CCLM.2005.107","article-title":"Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.","volume":"43","author":"K Pachmann","year":"2005","journal-title":"Clin Chem Lab Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0015624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T15:04:51Z","timestamp":1559919891000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0015624"}},"subtitle":[],"editor":[{"given":"Syed A.","family":"Aziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,1,10]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,1,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0015624","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,10]]}}}